Following approval of Japanese Regulator last quarter
Biocon announced that following the receipt of approval for its Insulin Glargine from the Japanese Regulator last quarter, its partner FUJIFILM Pharma Co. (FFP) has launched the product in Japan.Insulin Glargine BS Injection Kit has been developed and manufactured by Biocon, and is being commercialised by FFP in Japan.
Powered by Capital Market - Live News